Gyre Therapeutics, Inc 10-Q for FY2026 Q2
Gyre Therapeutics, Inc. (GYRE)
10-Q
2026-08-07
For: 2026-06-30
View Original
Added on
August 07, 2026
About this 10-Q
Gyre Therapeutics, Inc filed this 10-Q on August 7, 2026, covering the quarter ended June 30, 2026 (FY2026 Q2).
Headline figures
Quarter ended June 30, 2026, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $29.11M
- down 2.1% from $29.73M a year earlier
- Net loss
- $14.27M
- compared with a net loss of $2.24M a year earlier
- Diluted EPS
- -$0.12
- compared with -$0.03 a year earlier